Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

HKG:2563 Revenue

Beijing Biostar Pharmaceuticals had revenue of 36.64M CNY in the half year ending June 30, 2026, with 10.60% growth. This brings the company's total for the last twelve months to 55.21M, up 3.15% year-over-year. In the year 2025, Beijing Biostar Pharmaceuticals had annual revenue of 33.36M, down -53.57%. That makes Beijing Biostar Pharmaceuticals the 38,255th largest company in the world by revenue and 2,333rd in Hong Kong.

• Revenue (ttm): 55.21M CNY
• Revenue Growth: +3.15%
• P/S Ratio: 21.39
• Revenue / Employee: 434.75K CNY
• Employees: 127
• Market Cap: 1.36B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.36M	-38.50M	-53.57%
Dec 31, 2024	71.87M	5.23M	7.85%
Dec 31, 2023	66.64M	33.82M	103.03%
Dec 31, 2022	32.82M	-38.24M	-53.82%
Dec 31, 2021	71.06M	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 1, 2026

Data Sources Report a data error